Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

BluSky AI Inc. (BSAI) Outlines Scalable SkyMod Architecture as AI Infrastructure Demand Accelerates

The global demand for compute, energy, specialized chips, and data center infrastructure continues to grow at a pace that challenges traditional development timelines. What was once a steady progression in hardware and software has evolved into a race to maintain capacity, where organizations increasingly recognize that physical infrastructure is a critical limiting factor. Industry commentary […]

American Fusion(TM) Inc. (AMFN) Advances Texatron(TM) Development as Company Moves Toward Pre-Production Testing

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, is entering a new stage in its development efforts as the company moves beyond early prototype work and toward integrated testing of its Texatron(TM) fusion platform. The Texas-based company recently announced completion of the structural frame for its 5-megawatt Texatron(TM) pre-production unit, a milestone […]

Greenland Energy Company (NASDAQ: GLND) Advances Greenland Oil Strategy with Major Drilling Agreements

As global energy markets continue searching for long-term supply security outside traditional producing regions, Greenland is emerging as a frontier attracting renewed attention from explorers and investors alike. Greenland (NASDAQ: GLND), a recently formed energy exploration company focused on Greenland’s hydrocarbon potential, has taken a key step toward advancing its Arctic strategy with a newly […]

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Details Key Milestones and Future Drilling Plans at Emerging Growth Conference

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising. Nevada Organic Phosphate (CSE: NOP) (OTCQB: NOPFF), a Canadian-based leader in organic sedimentary phosphate exploration, is positioning itself around a segment of the fertilizer market that has gained increasing attention from both agricultural producers and policymakers: domestically sourced […]

CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Announces Exercised Warrants and Debentures; Positioned to Capitalize on the Current Precious Metals Market

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF)and may include paid advertising. CMX (CSE: CXC) (OTC: CXXMF), an exploration-stage company advancing the historic Clayton Silver Mine in Idaho, just announced that a total of 3,320,000 warrants were exercised for the purchase of 3,320,000 common shares of the company at $0.10 […]

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Looks to Expand Rare Earth Portfolio with Northern Ontario Hopkins Project

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF)and may include paid advertising. Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company focused on rare earth projects across North America, is continuing to expand its rare earth element exploration portfolio with the proposed acquisition of the Hopkins Rare Earths Project in […]

SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Is ‘One to Watch’

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF)and may include a paid advertisement. SureNano (CSE: SURE) (OTCQB: SURNF) is a Canadian life sciences company positioning itself within one of the most significant pharmaceutical developments of this generation: the rapid rise of GLP-1–based therapies for obesity and metabolic disease. Blockbuster drugs such as Ozempic(R), Wegovy(R), […]

SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Toward Clinical Stage with IND-Enabling Program for GLP GEP-44

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include a paid advertisement. SureNano Science (CSE: SURE) (OTCQB: SURNF), a Canadian life sciences company, has begun a key phase of preclinical development for its lead drug candidate GEP-44, a multi-receptor peptide targeting obesity and type 2 diabetes. The company is initiating […]

The Partnership Playbook: Oncotelic Therapeutics Inc. (OTLC) Advancing Its Pipeline Without Dilution

In clinical-stage biotechnology, the central challenge is rarely scientific discovery. It is capital. Advancing multiple therapeutic candidates through preclinical work, clinical trials, and regulatory approval requires sustained funding, and traditional financing routes often come at the cost of dilution or loss of asset control. With biotech capital markets remaining selective and the IPO window constrained, […]

 

From Our Blog

Oncotelic Therapeutics Inc. (OTLC) Proving Small Biotech Can Out-Innovate Big Pharma with 28 Million Reasons Why

May 21, 2026

Artificial intelligence is no longer a buzzword in the life sciences; rather, it is rapidly becoming the defining infrastructure layer of modern drug development. The companies that control the most intelligent platforms may ultimately control the industry’s future. Among the clinical-stage players quietly positioning themselves at the center of this shift is Oncotelic Therapeutics (OTCQB: […]

Rotate your device 90° to view site.